AMZN
Amazon.com, Inc.
AMZN has the edge over FNKO overall, supported by stronger valuation and lower modeled downside.
FNKO
Funko, Inc.
FNKO offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
FNKO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
FNKO's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over FNKO in the historical PE scenario, which offers more potential upside but is not a forecast.
FNKO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $0.84 | -88% |
| Fair | 18x | $1.29 | -81% |
| Forward | 28x | $6.90 | — |
| Expensive | 39x | $2.71 | -61% |
| Current | 99x | $6.90 | — |
Historical ranges are pointers, not guarantees.
FNKO's PE is in its expensive range at 99x. If earnings grow as analysts expect, today's price would be 28x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
FNKO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
FNKO has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over FNKO on earnings, with more consistent year-over-year improvement.
FNKO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.25 | +252% |
| Q3 2026 | $0.07 | +$1.32 |
| Q2 2026 | -$0.04 | +$1.15 |
| Q1 2026 | -$1.05 | -$0.70 |
| Q4 2025 | -$1.24 | -$0.96 |
| Q3 2025 | -$1.25 | -$0.81 |
| Q2 2025 | -$1.19 | -$0.36 |
| Q1 2025 | -$0.35 | +$2.12 |
| Q4 2024 | -$0.28 | +$2.91 |
FNKO has returned to profit: it earned $0.07 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over FNKO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over FNKO on profitability, with a higher operating margin.
FNKO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $258.3M | +3% |
| Q2 2026 | $207.7M | +7.4% |
| Q1 2026 | $200.9M | +5.3% |
| Q4 2025 | $273.1M | -7% |
| Q3 2025 | $250.9M | -14% |
| Q2 2025 | $193.5M | -22% |
| Q1 2025 | $190.7M | -12% |
| Q4 2024 | $293.7M | +0.9% |
FNKO's revenue fell from its 2022 peak and has held roughly level since: $258M last quarter, up 3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +3.2 points |
| Q2 2026 | 11% | +29 points |
| Q1 2026 | -4.8% | +7.4 points |
| Q4 2025 | 2.2% | +0.3 points |
| Q3 2025 | 2.6% | -1.4 points |
| Q2 2025 | -18% | -22 points |
| Q1 2025 | -12% | -5.3 points |
| Q4 2024 | 1.9% | +3 points |
FNKO's operating margin was 5.8% last quarter, up 3.2 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
FNKO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $24.7M | +631% |
| Q2 2026 | $2.7M | +$34.6M |
| Q1 2026 | $1.9M | +$30.8M |
| Q4 2025 | $19.2M | -60% |
| Q3 2025 | $3.4M | +$7.6M |
| Q2 2025 | -$31.8M | -187% |
| Q1 2025 | -$28.8M | -378% |
| Q4 2024 | $47.8M | +62% |
FNKO has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over FNKO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
FNKO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +649K shares |
| 1 year | +6.2% | +3.4M shares |
| 3 years | +20% | +9.9M shares |
| 5 years | +39% | +16.3M shares |
| Available history | +76% | +25.2M shares |
FNKO has 58M diluted shares, up 6.2% from a year ago.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over FNKO on leverage, with a lower net debt burden relative to earnings.
FNKO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.6x | Healthy |
| Q2 2026 | 1.9x | Healthy |
| Q1 2026 | 6.8x | High |
| Q4 2025 | 13.5x | High |
| Q3 2025 | 4.6x | High |
| Q2 2025 | 3.0x | Elevated |
| Q1 2025 | 1.4x | Healthy |
| Q4 2024 | 1.2x | Healthy |
FNKO's net debt is about 1.6 years of its operating earnings (EBITDA), down from 4.6 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
FNKO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 67.3 | Neutral |
FNKO's weekly RSI is 62 (neutral) and its Stochastic is 67 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over FNKO on valuation relative to its sector.
FNKO PE vs Consumer Cyclical Sector
| Metric | FNKO | Sector median | Relative |
|---|---|---|---|
| PE | 99x | 18x | 447% above |
| PE % | 94 | 47 | 47 pts above |
FNKO is trading at 99x earnings, a 447% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over FNKO on trend strength, trading above more of its moving averages.
FNKO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.41 | 7.6% above |
| 20 week MA | $6.10 | 13% above |
| 50 week MA | $4.99 | 38% above |
| 100 week MA | $5.61 | 23% above |
| 200 week MA | $7.30 | 5.5% below |
FNKO has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 5.5% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
FNKO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.9 | $10.7 | -37% |
| 2021 | $10.7 | $18.7 | +75% |
| 2022 | $18.7 | $9.89 | -47% |
| 2023 | $9.89 | $7.73 | -22% |
| 2024 | $7.73 | $13.2 | +71% |
| 2025 | $13.2 | $3.52 | -73% |
| 2026 YTD | $3.52 | $6.90 | +96% |
FNKO has the edge over AMZN on returns for 2026, with the stronger performance.